Your browser doesn't support javascript.
loading
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies.
Moreno, V; Calvo, E; Middleton, M R; Barlesi, F; Gaudy-Marqueste, C; Italiano, A; Romano, E; Marabelle, A; Chartash, E; Dobrenkov, K; Zhou, H; Connors, E C; Zhang, Y; Wermke, M.
  • Moreno V; START Madrid-FJD, Hospital Fundación Jimenez Diaz, Av. de los Reyes Católicos, 28040, Madrid, Spain. victor.moreno@startmadrid.com.
  • Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.
  • Middleton MR; Department of Oncology, University of Oxford, Oxford, UK.
  • Barlesi F; CEPCM CLIP2, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
  • Gaudy-Marqueste C; Medical Oncology Department, Gustave Roussy, Villejuif, France.
  • Italiano A; CEPCM CLIP2, Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France.
  • Romano E; Department of Medical Oncology, University of Bordeaux, Bordeaux, France.
  • Marabelle A; Early Phase Trials Unit, Institut Bergonié, Bordeaux, France.
  • Chartash E; Center for Cancer Immunotherapy, Dept of Oncology, INSERM U932, PSL Research University, Institut Curie, Paris, France.
  • Dobrenkov K; Medical Oncology Department, Gustave Roussy, Villejuif, France.
  • Zhou H; Merck & Co., Inc., Rahway, NJ, USA.
  • Connors EC; Merck & Co., Inc., Rahway, NJ, USA.
  • Zhang Y; Merck & Co., Inc., Rahway, NJ, USA.
  • Wermke M; Merck & Co., Inc., Rahway, NJ, USA.
Cancer Immunol Immunother ; 71(12): 2985-2998, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35596791

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article